Virgil T. Gaddy, Ph.D. - Publications

Affiliations: 
2007 Medical College of Georgia, Augusta, GA, United States 
Area:
Oncology, Cell Biology, Molecular Biology

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB, Barrett JT, Schoenlein PV. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Molecular Cancer Therapeutics. 7: 2977-87. PMID 18790778 DOI: 10.1158/1535-7163.Mct-08-0447  0.606
2007 Schoenlein PV, Hou M, Samaddar JS, Gaddy VT, Thangaraju M, Lewis J, Johnson M, Ganapathy V, Kallab A, Barrett JT. Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer. International Journal of Oncology. 31: 643-55. PMID 17671693 DOI: 10.3892/Ijo.31.3.643  0.584
2004 Gaddy VT, Barrett JT, Delk JN, Kallab AM, Porter AG, Schoenlein PV. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5215-25. PMID 15297425 DOI: 10.1158/1078-0432.Ccr-03-0637  0.608
Show low-probability matches.